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Abstract 
 
Objective: 
We compared the distribution by wealth of self-reported illness burden (estimated from 
validated scales, biomarker and reported symptoms) for angina, cataract, depression, diabetes 
and osteoarthritis, with the distribution of self-reported medical diagnosis and treatment. We 
aimed to determine if the greater illness burden borne by poorer participants was matched by 
appropriately higher levels of diagnosis and treatment.  
 
Design: 
The English Longitudinal Study of Ageing, a panel study of 12,765 participants aged 50 
years and older in four waves from 2004 to 2011, selected using a stratified random sample 
of households in England. Distribution of illness burden, diagnosis and treatment by wealth 
was estimated using regression analysis. 
 
Outcome measures:  
The main outcome measures were odds ratios (ORs) for the illness burden, diagnosis and 
treatment respectively, adjusted for age, sex and wealth. We estimated the illness burden for 
angina with the Rose Angina scale, diabetes with fasting glycosylated haemoglobin, 
depression with the Centre for Epidemiologic Studies Depression Scale, osteoarthritis with 
self-reported pain and disability, and cataract with self-reported poor vision. Medical 
diagnoses were self-reported for all conditions. Treatment was defined as beta-blocker 
prescription for angina, surgery for osteoarthritis and cataract, and receipt of pre-defined 
effective interventions for diabetes and depression. 
 
Results:  
Compared to the wealthiest, the least wealthy participant had substantially higher odds for 
illness burden from any of the five conditions at all four time points, with odds ratios ranging 
from 4.2 (95% confidence interval 2.6 to 6.8) for diabetes to 15.1 (11.4 to 20.0) for 
osteoarthritis. The odds ratios for diagnosis and treatment were smaller in all 5 conditions, 
and ranged from 0.9 (0.5 to 1.4) for diabetes treatment to 4.5 (3.3 to 6.0) for angina diagnosis.  
 
Conclusions:  
The substantially higher illness burden in less wealthy participants was not matched by 
appropriately higher levels of diagnosis and treatment. 
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Strengths and limitations of this study 
 
• The English Longitudinal Study of Ageing (ELSA) is a unique single source of detailed 
data on socioeconomic status and health, and this is the first study to compare inequalities 
in illness burden, self-reported medical diagnosis and treatment of long-term conditions in 
a panel study over time 
• Highly detailed measures of individual wealth were used alongside standardised scales 
and blood biomarker to assess the illness burden of depression, angina and diabetes 
• Standardised scales were not included in ELSA for osteoarthritis and cataract, so 
assessment of illness burden for these two conditions was based on attributed symptoms 
which were not specific for osteoarthritis and cataract 
• The study used self-reported data collected using an extensively tested structured 
questionnaire, but no information from medical records was collected 
• An analysis of pooled data from 4 waves of ELSA was used to maximise the sample size, 
and the main finding that less wealthy participants are relatively underdiagnosed requires 
validation in a larger longitudinal study. 
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Main text 
Introduction 
Poverty is associated with poor health, poor access to health care and poor health outcomes in 
many countries and across different health care systems 
1-3
. Much of this variation is caused 
by recognised broad social determinants of health 
4
. Considerable political effort has been 
directed at attempts to narrow health inequalities by reducing poverty and social exclusion. 
However, as health care has become more effective at improving health, its potential 
contribution to ameliorating health inequalities has increased. McKeown demonstrated in the 
1970s that health services had contributed little to health improvement 
5
, but the same claim 
could not be made today. The past 30 years have seen the introduction of a wide range of 
effective interventions, particularly for the prevention and management of chronic disease 
6
. 
Yet although these new interventions improve health, they are not necessarily applied equally 
across the population. Health inequalities will widen if effective services are offered, or taken 
up, with greater frequency by wealthier than less wealthy people. The reverse is also true, 
however, and there is an opportunity for healthcare to reduce social inequalities if it reaches 
those most in need 
7
. 
 
Little is known about pathways into poor health. The National Health Service provides 
medical care free at point-of-need to all UK residents, but there is scope for inequalities to 
occur in the pathway from identification of early symptoms through diagnosis and on to 
effective treatment. Individuals in more deprived social groups may be more reluctant to 
present to doctors with their symptoms and so may not receive a diagnosis 
8;9
. Diagnosis is a 
key step that has meaning for both patient and physician in all health systems, and ‘diagnostic 
confusion’ may act as a barrier to health care for vulnerable populations 
10
;
8;11
. Previous 
studies have found socio-economic variation in either diagnosis or treatment rates, but have 
not been able to compare inequalities in illness burden, rates of diagnosis and treatment 
modalities in the same population 
12-14
. 
 
The English Longitudinal Study of Ageing (ELSA) provides new data that can be used to 
identify barriers to equitable receipt of healthcare, and constitutes a unique source of 
information on illness burden, self-reported medical diagnosis and treatment. Other data 
sources cover symptoms, or diagnosis, or treatment, but no other single source covers all 
three. ELSA collects data on symptoms and validated markers of common health conditions, 
as well as diagnosis and treatment. It also contains detailed socio-demographic information, 
including direct measures of personal wealth, on a sample selected to be representative of the 
population of England aged 50 years and older. These data can be used to compare socio-
economic inequalities for several conditions, providing insight into a healthcare system with 
no direct financial barriers to treatment (the National Health Service in England). We aimed 
to assess socio-economic inequalities in the burden of illness (estimated by validated scales, 
biomarker, and reported symptoms) of angina, cataract, depression, diabetes and 
osteoarthritis, and compare them with inequalities in self-reported medical diagnosis and 
treatment, in order to determine whether key components of health care were received 
equitably. 
 
Methods 
We obtained data from the ELSA cohort, an interview survey of a sample of the population 
aged 50 years or older in England The sample was selected from households that had 
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previously responded to the Health Survey for England, and drawn from selected postcode 
sectors stratified by health authority and deprivation to be representative of adults aged 50 or 
more living in private households in England 
15
. Participants are interviewed in their homes 
or care homes every two years about a wide range of health, economic and social topics. We 
used data collected from core participants who had been interviewed in any of four waves of 
ELSA from wave 2 in 2004-5 until wave 5 in 2010-11. Wave 2 was the first wave to include 
questions on receipt of quality-indicated healthcare, and information was not collected on 
every variable in every wave. Ethical approval was received from the London Multi-Centre 
Research Ethics Committee. We studied five common and important long-term conditions: 
angina, diabetes, depression, osteoarthritis, and cataract. Effective treatment is freely 
available for all five conditions from the National Health Service. 
 
Variables 
We collected data on illness burden, self-reported medical diagnosis and treatment of angina, 
cataract, depression, diabetes and osteoarthritis. The illness burden for angina was defined as 
grade 2 on the Rose Angina scale (pain or discomfort in chest when walking at an ordinary 
pace on the level on most occasions or more often, which makes subject stop or slow down if 
occurs while walking, and which then goes away within 10 minutes, and which includes 
either sternum (any level), or left arm and left anterior chest). Illness burden for diabetes was 
defined as a fasting HbA1c level of >7.5% 
16
. Illness burden for depression was defined as a 
score of 3 or more on the eight-item Centre for Epidemiologic Studies Depression Scale 
(CES-D). The application of these standardised scales in ELSA has been described 
previously 
1
. Illness burden for osteoarthritis was defined as self-reported pain in the hip or 
knee of 5 or more on a scale of 0 to 10 
17
. Illness burden for cataract was defined broadly as 
reporting poor vision or blindness. Cataract is responsible for about a quarter of poor vision 
in the UK, so this measure is the least specific and includes those with other causes of poor 
vision, such as age-related macular degeneration, which is responsible for about a third of 
poor vision 
18;19
. 
 
A medical diagnosis was considered to exist if a participant answered ‘yes’ when asked 
whether a doctor had ever told them they had the condition of interest. For arthritis, a follow-
up question asked whether they had been told they had osteoarthritis, rheumatoid or other 
arthritis. 
 
Treatment for depression and diabetes was defined by reported achievement of quality of care 
indicators, derived through a robust process of literature reviews, expert panel assessment and 
piloting 
20;21
. For depression, the quality indicator was about receipt of treatment since the 
previous wave: ‘if a person is diagnosed with clinical depression, then antidepressive 
treatment, talking treatment or electroconvulsive treatment should be offered within 2 weeks 
after diagnosis unless within that period the patient has improved, or unless the patient has 
substance abuse or dependence, in which case treatment may wait until 8 weeks after the 
patient is in a drug-or alcohol-free state’. For diabetes, treatment was measurement of 
glycosylated haemoglobin or fructosamine levels in the preceding 12 months. Treatment for 
angina was defined as ever being offered or currently taking beta-blockers (ELSA variables 
hebeta or hebetb). Treatment for osteoarthritis and cataract were defined as reporting ever 
having had surgery for the condition. For osteoarthritis this excluded those with hips or knees 
replaced due to fracture. Data on hip and knee replacements were only available for 
respondents aged 60 and over, and so respondents aged less than 60 years (n= 3,186) were 
excluded from the analysis of osteoarthritis.  
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Wealth was defined as the sum of financial, physical and housing wealth plus state and 
private pension income. Age was categorised into three groups, 50-59 years, 60-74 years and 
75 years and older.  
 
Analysis 
We used two approaches to analysis, a main analysis using serial cross sectional data and 
then a subsidiary analysis using longitudinal data. Multivariable logistic regression analysis 
was used, with the outcome variables defined as one of illness burden, self-reported medical 
diagnosis or treatment for each of the five conditions in each cross-sectional wave (STATA 
statistical software version 12.1). This regression analysis was repeated for each of the four 
waves of ELSA from 2004 to 2011 separately and then ‘overall’ for all four waves combined. 
For the ‘overall’ analysis, the data were reshaped into ‘long’ format in Stata statistical 
software, with each participant having a separate record for each wave. Intra-person 
correlation of outcomes was accounted for using robust adjustment with Stata, with each 
participant’s unique identifier included in the regression equation as a cluster variable. 
Missing data were excluded from the analyses. 
 
The independent variables were age group, sex and slope order of inequality. We used the 
slope order of inequality as an independent variable to estimate the relationship between the 
outcome measures and the categorised measure of wealth 
22;23
. The slope order of inequality 
consisted of wealth quintiles with values of 0.1, 0.3, 0.5, 0.7 and 0.9, that is, the midpoints of 
each quintile on a scale of zero (least wealthy) to one (most wealthy). The slope order of 
inequality was modelled as a continuous variable, so that the slope or coefficient of a logit 
linear regression line across all five quintiles represents the difference in outcome between 
the hypothetically wealthiest and least wealthy participant. Exponentiating this slope 
coefficient results in an odds ratio, which is the ratio of the odds of the outcome in the 
wealthiest compared with the least wealthy participant. This odds ratio is also known as a 
relative index of inequality 
22
. Advantages of this method of quantifying inequality are that it 
includes all participants, instead of just comparing the highest and lowest quintiles, it 
accounts for the number of participants in each category and it provides a single overall 
measure of inequality.  
 
We included all participants in the main cross sectional analysis in order to compare the 
distribution of illness burden in the whole population with the distributions of diagnoses and 
treatments in the whole population. This meant that diagnosis was assessed even in those who 
did not meet the criteria for ‘illness burden’, and treatment was assessed even in those with 
no diagnosis. For the subsidiary analysis using longitudinal data, we estimated the odds ratio 
of receiving a diagnosis by a subsequent wave only for those who had met the criteria for 
‘illness burden’ in a previous wave, and then the likelihood of receiving treatment only for 
those who had received a diagnosis in a previous wave. This was a subsidiary analysis as the 
numbers of participants that could be followed over time in this manner was small, 
particularly for treatment in angina and depression. 
Results 
The whole sample (n=12,765) was composed of participants aged 50 years or more who had 
responded to at least one wave of ELSA from 2004-5 until 2010-11. The response rate in 
2004-5 was 82%.
24;25
 In wave 5 (2010-11), self-reported medical diagnosis for all five 
conditions increased as wealth decreased, for example in depression from 4% in the 
wealthiest quintile to 11% in the poorest (Table 1). There was little variation between the 
waves for each of the five conditions (Table 2). 
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The hypothetically least wealthy participant had substantially higher odds than the 
hypothetically most wealthy of meeting the criteria for ‘illness burden’ from any of the five 
conditions at all four time points (overall odds ratios (OR) ranged from 4.2 to 15.1) (Table 3). 
The least wealthy participant also had higher odds of diagnosis (ORs 1.1 to 4.5) and either no 
different or relatively small odds of treatment (ORs 0.9 to 2.6) (Table 3, Figure 1).  
 
For angina, the overall odds ratio for meeting the criteria for ‘illness burden’ was 7.6, 
indicating that the hypothetically least wealthy individual was seven times more likely to 
have angina symptoms (defined by the Rose angina scale) than the wealthiest. The odds ratio 
for self-reported medical diagnosis was 4.5, suggesting that some less wealthy people with 
angina symptoms had not received a diagnosis of angina, as the expected odds ratio for 
equitably distributed diagnosis would have been 7.6. The odds ratio for treatment was 3.2, 
and again the expected odds ratios for equitably distributed treatment would have been 7.6. 
For depression, the overall odds ratio for illness burden was 6.4, for medical diagnosis was 
3.3, and for treatment was 2.6, again suggesting that some poorer people with symptoms of 
depression were less likely to have received a diagnosis or indicated health care, as the 
expected odds ratios for equitably distributed treatment would have been 6.4.  
 
For diabetes, the overall odds ratio for illness burden was 4.2 and 4.0 for diagnosis, 
suggesting that for diabetes diagnosis was distributed equitably. However, the odds ratio for 
treatment was 0.9 and not statistically significantly different from 1, again suggesting that 
some less wealthy people with medically diagnosed diabetes had not received treatment, as 
the expected odds ratios for equitably distributed treatment would have been 4.2. 
 
The subsidiary analysis calculated the odds ratios of receiving a diagnosis by a subsequent 
wave only for those who had met the criteria for ‘illness burden’ for the relevant long term 
condition in a previous wave; and then the likelihood of receiving treatment only for those 
who had received a medical diagnosis in a previous wave. The substantial inequalities in the 
illness burden of conditions by wealth are identical to Table 3, as expected, and subsequently 
the numbers of eligible participants dwindle rapidly due to the nested nature of the analysis, 
with some wide confidence intervals and 9 out of 10 results not statistically significant 
(Supplemental file 1). 
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Table 1: Characteristics of ELSA participants at wave 5 (2010-11) and self-reported medical 
diagnosis of angina, cataract, depression, diabetes and osteoarthritis. 
 Whole 
sample 
N  
Angina 
 
% 
Cataract 
 
% 
Depression 
 
% 
Diabetes 
 
% 
Osteo-
arthritis 
% 
Sex Male 3,886 8.2 13.4 5.4 13.3 19.8 
 Female 4,843 6.3 20.4 7.8 9.4 32.9 
Age  
(years) 
50-59 1,906 2.2 3.7 10.1 7.2 17.1 
60-74 4,766 5.8 14.5 7.0 11.0 28.1 
75+ 2,057 15.0 36.6 2.9 15.0 34.1 
Wealth 
quintile* 
1 1,716 3.4 13.8 4.1 6.0 21.5 
2 1,714 4.9 15.5 5.9 8.0 24.2 
3 1,723 6.6 20.1 5.7 11.3 25.7 
4 1,716 8.2 18.6 6.7 13.6 31.6 
5 1,715 12.9 19.2 11.5 16.7 33.1 
 missing 145 5.5 9.7 4.8 9.7 20.0 
Total  8,729 7.2 17.3 6.7 11.1 27.1 
*1=wealthiest quintile, 5=least wealthy quintile 
 
 
Table 2. Prevalence of illness burden, self-reported medical diagnosis, and treatment for 
angina, cataract, depression, diabetes and osteoarthritis in four waves of ELSA 
 
 Angina 
N (%) 
Cataract 
N (%) 
Depression 
N (%) 
Diabetes 
N (%) 
Osteoarthritis 
N (%) 
Illness burden      
Wave 2 (2004-5) 397 (4.6) 308 (3.5) 2,037 (23.4) 160 (1.8) 1,106 (12.7) 
Wave 3 (2006-7) 300 (3.6) 317 (3.8) 1,929 (23.3) n/a 917 (11.1) 
Wave 4 (2008-9) 300 (3.1) 331 (3.5) 2,049 (21.4) 220 (2.3) 1,088 (11.4) 
Wave 5 (2010-11) 254 (2.9) 320 (3.7) 1,956 (22.4) n/a 1,046 (12.0) 
Medical diagnosis      
Wave 2 (2004-5) 668 (7.6) 1,050 (12.1) 402 (4.6) 715 (8.2) 1,861 (21.4) 
Wave 3 (2006-7) 591 (7.1) 1,294 (15.7) 490 (5.9) 935 (11.3) 1,952 (23.6) 
Wave 4 (2008-9) 645 (6.7) 1,421 (14.8) 601 (6.3) 1,215 (12.7) 2,262 (23.6) 
Wave 5 (2010-11) 655 (7.5) 1,566 (17.9) 602 (6.9) 1,413 (16.2) 2,416 (27.7) 
Treatment      
Wave 2 (2004-5) 85 (1.0) 535 (6.2) 98 (1.1) 552 (6.4) 202 (2.3) 
Wave 3 (2006-7) n/a 379 (4.9) n/a 618 (7.5) 141 (1.7) 
Wave 4 (2008-9) n/a 444 (4.6) 155 (1.6) 671 (7.0) 226 (2.4) 
Wave 5 (2010-11) 88 (1.0) 646 (7.4) n/a 748 (8.6) 208 (2.4) 
Total number of participants in each wave: wave 2: 8,688; wave 3: 8,268; wave 4: 9,578; wave 
5: 8,729 
n/a = data not available for that condition in that wave 
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Table 3. Illness burden, self-reported medical diagnosis and treatment of angina, cataract, 
depression, diabetes and osteoarthritis, comparing the least wealthy with the most wealthy: 
logistic regression. 
 
  Angina Cataract Depression Diabetes Osteoarthritis 
  Odds ratios (95% confidence interval) 
Wave 2*  
(2004-5) 
Illness burden 
5.6 
(3.8, 8.3) 
7.2 
(4.5, 11.5) 
5.1 
(4.3, 6.2) 
4.4 
(2.5, 8.0) 
11.0 
(8.1, 14.9) 
Medical diagnosis  
2.9 
(2.2, 3.9) 
1.3 
(1.0, 1.6) 
4.8 
(3.3, 7.0) 
3.1 
(2.3, 4.2) 
1.6 
(1.3, 2.0) 
Treatment 
2.6 
(1.2, 5.7) 
1.5 
(1.0, 2.2) 
0.6 
(0.1, 2.9) 
0.7 
(0.3, 1.5) 
1.1 
(0.7, 1.9) 
Wave 3*  
(2006-7) 
Illness burden 
8.7 
(5.5, 13.8) 
8.2 
(5.1, 13.1) 
6.9 
(5.7, 8.5) 
  
12.7 
(9.1, 17.8) 
Medical diagnosis 
4.9 
(3.6, 6.8) 
1.2 
(1.0, 1.5) 
0.7 
(0.4, 1.4) 
3.4 
(2.6, 4.4) 
0.6 
(0.4, 0.8) 
Treatment   
1.3 
(0.8, 1.9) 
  
1.2 
(0.6, 2.4) 
1.0 
(0.6, 1.9) 
Wave 4*  
(2008-9) 
Illness burden 
6.7 
(4.2, 10.5) 
5.5 
(3.6, 8.6) 
5.9 
(4.9, 7.1) 
3.9 
(2.4, 6.4) 
14.0 
(10.3, 19.1) 
Medical diagnosis 
4.3 
(3.2, 5.9) 
1.1 
(0.9, 1.4) 
0.7 
(0.4, 1.2) 
3.9 
(3.1, 5.1) 
0.6 
(0.4, 0.8) 
Treatment   
1.1 
(0.7, 1.6) 
2.4 
(1.0, 5.9) 
0.2 
(0.1, 0.6) 
1.0 
(0.6, 1.6) 
Wave 5*  
(2010-11) 
Illness burden 
8.4 
(5.1, 13.7) 
6.2 
(3.9, 9.9) 
5.9 
(4.8, 7.1) 
  
16.0 
(11.7, 21.8) 
Medical diagnosis 
5.3 
(3.9, 7.3) 
1.3 
(1.0, 1.5) 
1.7 
(1.0, 2.8) 
4.3 
(3.4, 5.4) 
0.6 
(0.4, 0.8) 
Treatment 
3.3 
(1.5, 7.3) 
1.8 
(1.2, 2.6) 
  
0.8 
(0.4, 1.6) 
1.2 
(0.7, 2.0) 
Overall† 
Illness burden 
7.6 
(5.4, 10.8) 
8.0 
(5.4, 11.9) 
6.4 
(5.5, 7.5) 
4.2 
(2.6, 6.8) 
15.1 
(11.4, 20.0) 
Medical diagnosis 
4.5 
(3.3, 6.0) 
1.3 
(1.1, 1.5) 
3.3 
(2.4, 4.5) 
4.0 
(3.1, 5.2) 
1.1 
(0.9, 1.3) 
Treatment 
3.2 
(1.7, 6.0) 
1.3 
(1.0, 1.8) 
2.6 
(1.1, 6.1) 
0.9 
(0.5, 1.4) 
1.2 
(0.8, 1.6) 
*Odds ratios adjusted for age group and sex  
†Odds ratios adjusted for age group, sex and unique participant identifier  
**Analyses for osteoarthritis excluded those younger than 60 years, as data on osteoarthritis treatment were only collected 
in those aged 60 or over. 
Statistically significant odds ratios (where the 95% confidence intervals do not include 1 before rounding to one decimal 
place) are shown in bold 
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Figure 1. Illness burden (in blue), self-reported medical diagnosis (in green), and treatment 
(in red) of angina, cataract, depression, diabetes and osteoarthritis, comparing the least 
wealthy with the most wealthy: Overall odds ratios (adjusted for age and sex) and 95% 
confidence bars: logistic regression  
 
INSERT FIGURE 1 HERE 
Discussion 
We found that while there were strong inverse associations between wealth and the burden of 
illness (based on validated scales, symptoms and biomarker) of a long-term condition, there 
were smaller or absent inequalities in receipt of self-reported medical diagnosis or treatment 
for the conditions considered. This suggests that the substantially higher illness burden in less 
wealthy participants was not matched by appropriately higher levels of diagnosis and 
treatment, and that equitable receipt of a medical diagnosis may have an important role in 
reducing inequalities in health.  
 
ELSA is a unique single source of detailed data on socioeconomic status and health, and this 
is the first study to compare inequalities in illness burden, self-reported medical diagnosis and 
treatment of long-term conditions in a panel study over time. ELSA used robust measures of 
individual socio-economic position, and standardised scales and blood biomarker to assess 
health status. This exploratory study has some limitations and the results should be 
interpreted with caution and tested in subsequent research. Whilst standardised measures 
were used to estimate the illness burden of depression, angina and diabetes, symptoms alone 
were used for osteoarthritis and cataract, and the attributed symptoms were not specific for 
osteoarthritis and cataract. However, this lack of specificity is unlikely to vary with wealth, 
and so is not likely to be an important source of bias. Self-reported data may be a source of 
bias if self-report varies by factors other than objective health status, such as wealth or social 
experience. This is a recognised problem with some self-reported morbidity data, but is less 
of a problem with sensory assessment for  pain, which is essentially self-perceived, and 
where self-report is the best means of assessment 
26
. 
 
We have not adjusted for health-related factors that are also more prevalent in poorer 
populations, such as smoking, obesity and comorbidity, because none of these are a reason 
for not making a diagnosis. Comorbid conditions are commoner in those with lower socio-
economic status, but there is no evidence that comorbidities make a new diagnosis less likely. 
On the contrary, a higher number of comorbid conditions in older people may be associated 
with higher quality of care 
27
. We found different patterns in different conditions, which fits 
with other research showing that wealth acts differently in different conditions, and for 
example, has no association with referral for post-menopausal bleeding 
28
. Major national 
policy interventions such as the Quality and Outcomes Framework payment for performance 
scheme in primary care 
29
 have been associated with improved healthcare for included 
conditions such as angina and diabetes, more than for excluded conditions such osteoarthritis 
and poor vision 
30-32
. 
 
The serial cross-sectional analysis of 4 waves of ELSA included all eligible participants in 
each wave in order to maximise the sample size. This approach meant that some participants 
with a diagnosed condition would no longer have had symptoms or raised biomarkers, if they 
were being successfully treated. Examples would be diabetic participants whose blood sugar 
levels were being successfully controlled by treatment, and participants with successfully 
treated depression. We therefore checked our main results with the secondary (longitudinal) 
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analysis, which assessed subsequent diagnosis in those had met the criteria for ‘illness 
burden’, and subsequent treatment in those with a medical diagnosis, but the number of 
participants who could be followed through the waves in this way was too small to allow 
meaningful conclusions to be drawn from the results. 
 
Our results fit with previous findings that a greater proportion of people in deprived groups 
had Rose angina, but there was no difference in the proportions receiving a general 
practitioner diagnosis of coronary heart disease 
14
. Care-seeking behaviour and patient 
preferences may differ with wealth. Given the same information, patients may want fewer 
medical interventions than their doctors recommend 
33;34
, and pessimism about availability of 
treatment may make older people reluctant to seek help 
35
. Older people may view living with 
symptoms (such as pain, or emotional problems) as a normal part of ageing 
36
. The response 
of the primary care physician may also vary with the wealth of the patient. For example, the 
physician might be more likely to consider symptoms of breathlessness as a medical problem 
requiring a diagnosis, whereas aches and pains, poor vision, and low mood might be 
considered part of the tapestry of life, or the natural ageing process. Comorbidity is more 
common in deprived populations, and may make diagnosis of all conditions harder for 
doctors within the constraints of a short consultation 
37
. 
 
At a system level, the results may be partially explained by wealthier people living in areas 
where there are more healthcare resources. Wennberg introduced the concept of ‘supply-
sensitive care’ to describe how the quantity of healthcare resources allocated to a particular 
population was a major determinant of the frequency of use of health services by that 
population, and gives an example in which ‘a doubling of the supply of internists or 
cardiologists results in roughly a halving of the interval between repeat visits’ 
38;39
. Where 
healthcare resources are relatively plentiful, patients with chronic diseases will consult more, 
use more diagnostic tests, and be referred to hospital more. Further research could helpfully 
investigate whether those missing out on diagnosis are not accessing health services, or are 
seeing a doctor but not being diagnosed. The participants were selected to be nationally 
representative of the population of England, and so the findings are likely to be generalisable 
to England, but not to countries with different healthcare systems.  If validated, our findings 
that inequalities in receipt of diagnoses are potential barriers to equitable healthcare for five 
common long-term conditions, suggest that future policy interventions to reduce socio-
economic inequalities in healthcare should consider improving access to diagnosis as well as 
treatment.  
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Abstract 
 
Objective: 
We compared the distribution by wealth of self-reported illness burden (estimated from 
validated scales, biomarker and reported symptoms) for angina, cataract, depression, diabetes 
and osteoarthritis, with the distribution of self-reported medical diagnosis and treatment. We 
aimed to determine if the greater illness burden borne by poorer participants was matched by 
appropriately higher levels of diagnosis and treatment.  
 
Design: 
The English Longitudinal Study of Ageing, a panel study of 12,765 participants aged 50 
years and older in four waves from 2004 to 2011, selected using a stratified random sample 
of households in England. Distribution of illness burden, diagnosis and treatment by wealth 
was estimated using regression analysis. 
 
Outcome measures:  
The main outcome measures were odds ratios (ORs) for the illness burden, diagnosis and 
treatment respectively, adjusted for age, sex and wealth. We estimated the illness burden for 
angina with the Rose Angina scale, diabetes with fasting glycosylated haemoglobin, 
depression with the Centre for Epidemiologic Studies Depression Scale, osteoarthritis with 
self-reported pain and disability, and cataract with self-reported poor vision. Medical 
diagnoses were self-reported for all conditions. Treatment was defined as beta-blocker 
prescription for angina, surgery for osteoarthritis and cataract, and receipt of pre-defined 
effective interventions for diabetes and depression. 
 
Results:  
Compared to the wealthiest, the least wealthy participant had substantially higher odds for 
illness burden from any of the five conditions at all four time points, with odds ratios ranging 
from 4.2 (95% confidence interval 2.6 to 6.8) for diabetes to 15.1 (11.4 to 20.0) for 
osteoarthritis. The odds ratios for diagnosis and treatment were smaller in all 5 conditions, 
and ranged from 0.9 (0.5 to 1.4) for diabetes treatment to 4.5 (3.3 to 6.0) for angina diagnosis.  
 
Conclusions:  
The substantially higher illness burden in less wealthy participants was not matched by 
appropriately higher levels of diagnosis and treatment. 
 
 
  
Page 18 of 34
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
3 
 
Strengths and limitations of this study 
 
• The English Longitudinal Study of Ageing (ELSA) is a unique single source of detailed 
longitudinal data on socioeconomic status and health, and this is the first study to 
compare inequalities in illness burden, self-reported medical diagnosis and treatment of 
long-term conditions in a longitudinal panel study over time 
• Highly detailed measures of individual wealth were used alongside standardised scales 
and blood biomarker to assess the illness burden of depression, angina and diabetes 
• Standardised scales were not included in ELSA for osteoarthritis and cataract, so 
assessment of illness burden for these two conditions was based on attributed symptoms 
which were not specific for osteoarthritis and cataract 
• The study used self-reported data collected using an extensively tested structured 
questionnaire, but no information from medical records was collected 
• An analysis of pooled data from 4 waves of ELSA was used to maximise the sample size, 
and the main finding that less wealthy participants are relatively underdiagnosed requires 
validation in a larger longitudinal study. 
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Main text 
Introduction 
Poverty is associated with poor health, poor access to health care and poor health outcomes in 
many countries and across different health care systems 
1-3
. Much of this variation is caused 
by recognised broad social determinants of health 
4
. Considerable political effort has been 
directed at attempts to narrow health inequalities by reducing poverty and social exclusion. 
However, as health care has become more effective at improving health, its potential 
contribution to ameliorating health inequalities has increased. McKeown demonstrated in the 
1970s that health services had contributed little to health improvement 
5
, but the same claim 
could not be made today. The past 30 years have seen the introduction of a wide range of 
effective interventions, particularly for the prevention and management of chronic disease 
6
. 
Yet although these new interventions improve health, they are not necessarily applied equally 
across the population. Health inequalities will widen if effective services are offered, or taken 
up, with greater frequency by wealthier than less wealthy people. The reverse is also true, 
however, and there is an opportunity for healthcare to reduce social inequalities if it reaches 
those most in need 
7
. 
 
Little is known about pathways into poor health. The National Health Service provides 
medical care free at point-of-need to all UK residents, but there is scope for inequalities to 
occur in the pathway from identification of early symptoms through diagnosis and on to 
effective treatment. Individuals in more deprived social groups may be more reluctant to 
present to doctors with their symptoms and so may not receive a diagnosis 
8;9
. Diagnosis is a 
key step that has meaning for both patient and physician in all health systems, and ‘diagnostic 
confusion’ may act as a barrier to health care for vulnerable populations 
10
;
8;11
. Previous 
studies have found socio-economic variation in either diagnosis or treatment rates, but have 
not been able to compare inequalities in illness burden, rates of diagnosis and treatment 
modalities in the same population 
12-14
. 
 
The English Longitudinal Study of Ageing (ELSA) provides new data that can be used to 
identify barriers to equitable receipt of healthcare, and constitutes a unique source of 
information on illness burden, self-reported medical diagnosis and treatment. Other data 
sources cover symptoms, or diagnosis, or treatment, but no other single source covers all 
three. ELSA collects data on symptoms and validated markers of common health conditions, 
as well as diagnosis and treatment. It also contains detailed socio-demographic information, 
including direct measures of personal wealth, on a sample selected to be representative of the 
population of England aged 50 years and older. These data can be used to compare socio-
economic inequalities for several conditions, providing insight into a healthcare system with 
no direct financial barriers to treatment (the National Health Service in England). We aimed 
to assess socio-economic inequalities in the burden of illness (estimated by validated scales, 
biomarker, and reported symptoms) of angina, cataract, depression, diabetes and 
osteoarthritis, and compare them with inequalities in self-reported medical diagnosis and 
treatment, in order to determine whether key components of health care were received 
equitably. 
 
Methods 
We obtained data from the ELSA cohort, an interview survey of a sample of the population 
aged 50 years or older in England The sample was selected from households that had 
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previously responded to the Health Survey for England, and drawn from selected postcode 
sectors stratified by health authority and deprivation to be representative of adults aged 50 or 
more living in private households in England 
15
. Participants are interviewed in their homes 
or care homes every two years about a wide range of health, economic and social topics. We 
used data collected from core participants who had been interviewed in any of four waves of 
ELSA from wave 2 in 2004-5 until wave 5 in 2010-11. Wave 2 was the first wave to include 
questions on receipt of quality-indicated healthcare, and information was not collected on 
every variable in every wave. Ethical approval was received from the London Multi-Centre 
Research Ethics Committee. We studied five common and important long-term conditions: 
angina, diabetes, depression, osteoarthritis, and cataract. Effective treatment is freely 
available for all five conditions from the National Health Service. 
 
Variables 
We collected data on illness burden, self-reported medical diagnosis and treatment of angina, 
cataract, depression, diabetes and osteoarthritis. The illness burden for angina was defined as 
grade 2 on the Rose Angina scale (pain or discomfort in chest when walking at an ordinary 
pace on the level on most occasions or more often, which makes subject stop or slow down if 
occurs while walking, and which then goes away within 10 minutes, and which includes 
either sternum (any level), or left arm and left anterior chest). Illness burden for diabetes was 
defined as a fasting HbA1c level of >7.5% 
16
. Illness burden for depression was defined as a 
score of 3 or more on the eight-item Centre for Epidemiologic Studies Depression Scale 
(CES-D). The application of these standardised scales in ELSA has been described 
previously 
1
. Illness burden for osteoarthritis was defined as self-reported pain in the hip or 
knee of 5 or more on a scale of 0 to 10 
17
. Illness burden for cataract was defined broadly as 
reporting poor vision or blindness. Cataract is responsible for about a quarter of poor vision 
in the UK, so this measure is the least specific and includes those with other causes of poor 
vision, such as age-related macular degeneration, which is responsible for about a third of 
poor vision 
18;19
. 
 
A medical diagnosis was considered to exist if a participant answered ‘yes’ when asked 
whether a doctor had ever told them they had the condition of interest. For arthritis, a follow-
up question asked whether they had been told they had osteoarthritis, rheumatoid or other 
arthritis. 
 
Treatment for depression and diabetes was defined by reported achievement of quality of care 
indicators, derived through a robust process of literature reviews, expert panel assessment and 
piloting 
20;21
. For depression, the quality indicator was about receipt of treatment since the 
previous wave: ‘if a person is diagnosed with clinical depression, then antidepressive 
treatment, talking treatment or electroconvulsive treatment should be offered within 2 weeks 
after diagnosis unless within that period the patient has improved, or unless the patient has 
substance abuse or dependence, in which case treatment may wait until 8 weeks after the 
patient is in a drug-or alcohol-free state’. For diabetes, treatment was measurement of 
glycosylated haemoglobin or fructosamine levels in the preceding 12 months. Treatment for 
angina was defined as ever being offered or currently taking beta-blockers (ELSA variables 
hebeta or hebetb). Treatment for osteoarthritis and cataract were defined as reporting ever 
having had surgery for the condition. For osteoarthritis this excluded those with hips or knees 
replaced due to fracture. Data on hip and knee replacements were only available for 
respondents aged 60 and over, and so respondents aged less than 60 years (n= 3,186) were 
excluded from the analysis of osteoarthritis.  
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Wealth was defined as the sum of financial, physical and housing wealth plus state and 
private pension income. Age was categorised into three groups, 50-59 years, 60-74 years and 
75 years and older.  
 
Analysis 
We used two approaches to analysis, a main analysis using serial cross sectional data and 
then a subsidiary analysis using longitudinal data. Multivariable logistic regression analysis 
was used, with the outcome variables defined as one of illness burden, self-reported medical 
diagnosis or treatment for each of the five conditions in each cross-sectional wave (STATA 
statistical software version 12.1). This regression analysis was repeated for each of the four 
waves of ELSA from 2004 to 2011 separately and then ‘overall’ for all four waves combined. 
For the ‘overall’ analysis, the data were reshaped into ‘long’ format in Stata statistical 
software, with each participant having a separate record for each wave. Intra-person 
correlation of outcomes was accounted for using robust adjustment with Stata, with each 
participant’s unique identifier included in the regression equation as a cluster variable. 
Missing data were excluded from the analyses. 
 
The independent variables were age group, sex and slope order of inequality. We used the 
slope order of inequality as an independent variable to estimate the relationship between the 
outcome measures and the categorised measure of wealth 
22;23
. The slope order of inequality 
consisted of wealth quintiles with values of 0.1, 0.3, 0.5, 0.7 and 0.9, that is, the midpoints of 
each quintile on a scale of zero (least wealthy) to one (most wealthy). The slope order of 
inequality was modelled as a continuous variable, so that the slope or coefficient of a logit 
linear regression line across all five quintiles represents the difference in outcome between 
the hypothetically wealthiest and least wealthy participant. Exponentiating this slope 
coefficient results in an odds ratio, which is the ratio of the odds of the outcome in the 
wealthiest compared with the least wealthy participant. This odds ratio is also known as a 
relative index of inequality 
22
. Advantages of this method of quantifying inequality are that it 
includes all participants, instead of just comparing the highest and lowest quintiles, it 
accounts for the number of participants in each category and it provides a single overall 
measure of inequality.  
 
We included all participants in the main cross sectional analysis in order to compare the 
distribution of illness burden in the whole population with the distributions of diagnoses and 
treatments in the whole population. This meant that diagnosis was assessed even in those who 
did not meet the criteria for ‘illness burden’, and treatment was assessed even in those with 
no diagnosis. For the subsidiary analysis using longitudinal data, we estimated the odds ratio 
of receiving a diagnosis by a subsequent wave only for those who had met the criteria for 
‘illness burden’ in a previous wave, and then the likelihood of receiving treatment only for 
those who had received a diagnosis in a previous wave. This was a subsidiary analysis as the 
numbers of participants that could be followed over time in this manner was small, 
particularly for treatment in angina and depression. 
Results 
The whole sample (n=12,765) was composed of participants aged 50 years or more who had 
responded to at least one wave of ELSA from 2004-5 until 2010-11. The response rate in 
2004-5 was 82%.
24;25
 In wave 5 (2010-11), over half of the sample of 8,729 were women, or 
were aged between 60 and 74 years (Table 1). Sself-reported medical diagnosis for all five 
conditions increased as wealth decreased, for example in depression from 4% in the 
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wealthiest quintile to 11% in the poorest (Table 1). There was little variation between the 
waves for each of the five conditions (Table 2). 
 
The hypothetically least wealthy participant had substantially higher odds than the 
hypothetically most wealthy of meeting the criteria for ‘illness burden’ from any of the five 
conditions at all four time points (overall odds ratios (OR) ranged from 4.2 to 15.1) (Table 3). 
The least wealthy participant also had higher odds of diagnosis (ORs 1.1 to 4.5) and either no 
different or relatively small odds of treatment (ORs 0.9 to 2.6) (Table 3, Figure 1).  
 
For angina, the overall odds ratio for meeting the criteria for ‘illness burden’ was 7.6, 
indicating that the hypothetically least wealthy individual was seven times more likely to 
have angina symptoms (defined by the Rose angina scale) than the wealthiest. The odds ratio 
for self-reported medical diagnosis was 4.5, suggesting that some less wealthy people with 
angina symptoms had not received a diagnosis of angina, as the expected odds ratio for 
equitably distributed diagnosis would have been 7.6. The odds ratio for treatment was 3.2, 
and again the expected odds ratios for equitably distributed treatment would have been 7.6. 
For depression, the overall odds ratio for illness burden was 6.4, for medical diagnosis was 
3.3, and for treatment was 2.6, again suggesting that some poorer people with symptoms of 
depression were less likely to have received a diagnosis or indicated health care, as the 
expected odds ratios for equitably distributed treatment would have been 6.4.  
 
For diabetes, the overall odds ratio for illness burden was 4.2 and 4.0 for diagnosis, 
suggesting that for diabetes diagnosis was distributed equitably. However, the odds ratio for 
treatment was 0.9 and not statistically significantly different from 1, again suggesting that 
some less wealthy people with medically diagnosed diabetes had not received treatment, as 
the expected odds ratios for equitably distributed treatment would have been 4.2. 
 
The subsidiary analysis calculated the odds ratios of receiving a diagnosis by a subsequent 
wave only for those who had met the criteria for ‘illness burden’ for the relevant long term 
condition in a previous wave; and then the likelihood of receiving treatment only for those 
who had received a medical diagnosis in a previous wave. The substantial inequalities in the 
illness burden of conditions by wealth are identical to Table 3, as expected, and subsequently 
the numbers of eligible participants dwindle rapidly due to the nested nature of the analysis, 
with some wide confidence intervals and 9 out of 10 results not statistically significant 
(Supplemental file 1). 
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Table 1: Characteristics of ELSA participants at wave 5 (2010-11) and self-reported medical 
diagnosis of angina, cataract, depression, diabetes and osteoarthritis. 
 Whole 
sample 
N  
Angina 
 
% 
Cataract 
 
% 
Depression 
 
% 
Diabetes 
 
% 
Osteo-
arthritis 
% 
Sex Male 3,886 8.2 13.4 5.4 13.3 19.8 
 Female 4,843 6.3 20.4 7.8 9.4 32.9 
Age  
(years) 
50-59 1,906 2.2 3.7 10.1 7.2 17.1 
60-74 4,766 5.8 14.5 7.0 11.0 28.1 
75+ 2,057 15.0 36.6 2.9 15.0 34.1 
Wealth 
quintile* 
1 1,716 3.4 13.8 4.1 6.0 21.5 
2 1,714 4.9 15.5 5.9 8.0 24.2 
3 1,723 6.6 20.1 5.7 11.3 25.7 
4 1,716 8.2 18.6 6.7 13.6 31.6 
5 1,715 12.9 19.2 11.5 16.7 33.1 
 missing 145 5.5 9.7 4.8 9.7 20.0 
Total  8,729 7.2 17.3 6.7 11.1 27.1 
*1=wealthiest quintile, 5=least wealthy quintile 
 
 
Table 2. Prevalence of illness burden, self-reported medical diagnosis, and treatment for 
angina, cataract, depression, diabetes and osteoarthritis in four waves of ELSA 
 
 Angina 
N (%) 
Cataract 
N (%) 
Depression 
N (%) 
Diabetes 
N (%) 
Osteoarthritis 
N (%) 
Illness burden      
Wave 2 (2004-5) 397 (4.6) 308 (3.5) 2,037 (23.4) 160 (1.8) 1,106 (12.7) 
Wave 3 (2006-7) 300 (3.6) 317 (3.8) 1,929 (23.3) n/a 917 (11.1) 
Wave 4 (2008-9) 300 (3.1) 331 (3.5) 2,049 (21.4) 220 (2.3) 1,088 (11.4) 
Wave 5 (2010-11) 254 (2.9) 320 (3.7) 1,956 (22.4) n/a 1,046 (12.0) 
Medical diagnosis      
Wave 2 (2004-5) 668 (7.6) 1,050 (12.1) 402 (4.6) 715 (8.2) 1,861 (21.4) 
Wave 3 (2006-7) 591 (7.1) 1,294 (15.7) 490 (5.9) 935 (11.3) 1,952 (23.6) 
Wave 4 (2008-9) 645 (6.7) 1,421 (14.8) 601 (6.3) 1,215 (12.7) 2,262 (23.6) 
Wave 5 (2010-11) 655 (7.5) 1,566 (17.9) 602 (6.9) 1,413 (16.2) 2,416 (27.7) 
Treatment      
Wave 2 (2004-5) 85 (1.0) 535 (6.2) 98 (1.1) 552 (6.4) 202 (2.3) 
Wave 3 (2006-7) n/a 379 (4.9) n/a 618 (7.5) 141 (1.7) 
Wave 4 (2008-9) n/a 444 (4.6) 155 (1.6) 671 (7.0) 226 (2.4) 
Wave 5 (2010-11) 88 (1.0) 646 (7.4) n/a 748 (8.6) 208 (2.4) 
Total number of participants in each wave: wave 2: 8,688; wave 3: 8,268; wave 4: 9,578; wave 
5: 8,729 
n/a = data not available for that condition in that wave 
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Table 3. Illness burden, self-reported medical diagnosis and treatment of angina, cataract, 
depression, diabetes and osteoarthritis, comparing the least wealthy with the most wealthy: 
logistic regression. 
 
  Angina Cataract Depression Diabetes Osteoarthritis 
  Odds ratios (95% confidence interval) 
Wave 2*  
(2004-5) 
Illness burden 
5.6 
(3.8, 8.3) 
7.2 
(4.5, 11.5) 
5.1 
(4.3, 6.2) 
4.4 
(2.5, 8.0) 
11.0 
(8.1, 14.9) 
Medical diagnosis  
2.9 
(2.2, 3.9) 
1.3 
(1.0, 1.6) 
4.8 
(3.3, 7.0) 
3.1 
(2.3, 4.2) 
1.6 
(1.3, 2.0) 
Treatment 
2.6 
(1.2, 5.7) 
1.5 
(1.0, 2.2) 
0.6 
(0.1, 2.9) 
0.7 
(0.3, 1.5) 
1.1 
(0.7, 1.9) 
Wave 3*  
(2006-7) 
Illness burden 
8.7 
(5.5, 13.8) 
8.2 
(5.1, 13.1) 
6.9 
(5.7, 8.5) 
  
12.7 
(9.1, 17.8) 
Medical diagnosis 
4.9 
(3.6, 6.8) 
1.2 
(1.0, 1.5) 
0.7 
(0.4, 1.4) 
3.4 
(2.6, 4.4) 
0.6 
(0.4, 0.8) 
Treatment   
1.3 
(0.8, 1.9) 
  
1.2 
(0.6, 2.4) 
1.0 
(0.6, 1.9) 
Wave 4*  
(2008-9) 
Illness burden 
6.7 
(4.2, 10.5) 
5.5 
(3.6, 8.6) 
5.9 
(4.9, 7.1) 
3.9 
(2.4, 6.4) 
14.0 
(10.3, 19.1) 
Medical diagnosis 
4.3 
(3.2, 5.9) 
1.1 
(0.9, 1.4) 
0.7 
(0.4, 1.2) 
3.9 
(3.1, 5.1) 
0.6 
(0.4, 0.8) 
Treatment   
1.1 
(0.7, 1.6) 
2.4 
(1.0, 5.9) 
0.2 
(0.1, 0.6) 
1.0 
(0.6, 1.6) 
Wave 5*  
(2010-11) 
Illness burden 
8.4 
(5.1, 13.7) 
6.2 
(3.9, 9.9) 
5.9 
(4.8, 7.1) 
  
16.0 
(11.7, 21.8) 
Medical diagnosis 
5.3 
(3.9, 7.3) 
1.3 
(1.0, 1.5) 
1.7 
(1.0, 2.8) 
4.3 
(3.4, 5.4) 
0.6 
(0.4, 0.8) 
Treatment 
3.3 
(1.5, 7.3) 
1.8 
(1.2, 2.6) 
  
0.8 
(0.4, 1.6) 
1.2 
(0.7, 2.0) 
Overall† 
Illness burden 
7.6 
(5.4, 10.8) 
8.0 
(5.4, 11.9) 
6.4 
(5.5, 7.5) 
4.2 
(2.6, 6.8) 
15.1 
(11.4, 20.0) 
Medical diagnosis 
4.5 
(3.3, 6.0) 
1.3 
(1.1, 1.5) 
3.3 
(2.4, 4.5) 
4.0 
(3.1, 5.2) 
1.1 
(0.9, 1.3) 
Treatment 
3.2 
(1.7, 6.0) 
1.3 
(1.0, 1.8) 
2.6 
(1.1, 6.1) 
0.9 
(0.5, 1.4) 
1.2 
(0.8, 1.6) 
*Odds ratios adjusted for age group and sex  
†Odds ratios adjusted for age group, sex and unique participant identifier  
**Analyses for osteoarthritis excluded those younger than 60 years, as data on osteoarthritis treatment were only collected 
in those aged 60 or over. 
Statistically significant oOdds ratios (where the 95% confidence intervals do not include 1 (before rounding to one 
decimal place) are shown in bold 
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Figure 1. Illness burden (in blue), self-reported medical diagnosis (in green), and treatment 
(in red) of angina, cataract, depression, diabetes and osteoarthritis, comparing the least 
wealthy with the most wealthy: Overall odds ratios (adjusted for age and sex) and 95% 
confidence bars: logistic regression  (binomial regression) 
 
 
 
Discussion 
We found that while there were strong inverse associations between wealth and the burden of 
illness (based on validated scales, symptoms and biomarker) of a long-term condition, there 
were smaller or absent inequalities in receipt of self-reported medical diagnosis or treatment 
for the conditions considered. This suggests that the substantially higher illness burden in less 
wealthy participants was not matched by appropriately higher levels of diagnosis and 
treatment, and that equitable receipt of a medical diagnosis may have an important role in 
reducing inequalities in health.  
 
ELSA is a unique single source of detailed longitudinal data on socioeconomic status and 
health, and this is the first study to compare inequalities in illness burden, self-reported 
medical diagnosis and treatment of long-term conditions in a longitudinal panel study over 
time. ELSA used robust measures of individual socio-economic position, and standardised 
scales and blood biomarker to assess health status. This exploratory study has some 
limitations and the results should be interpreted with caution and tested in subsequent 
research. Whilst standardised measures were used to estimate the illness burden of 
depression, angina and diabetes, symptoms alone were used for osteoarthritis and cataract, 
and the attributed symptoms were not specific for osteoarthritis and cataract. However, this 
lack of specificity is unlikely to vary with wealth, and so is not likely to be an important 
source of bias. Self-reported data may be a source of bias if self-report varies by factors other 
than objective health status, such as wealth or social experience. This is a recognised problem 
with some self-reported morbidity data, but is less of a problem with sensory assessment for  
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pain, which is essentially self-perceived, and where self-report is the best means of 
assessment 
26
. 
 
We have not adjusted for health-related factors that are also more prevalent in poorer 
populations, such as smoking, obesity and comorbidity, because none of these are a reason 
for not making a diagnosis. Comorbid conditions are commoner in those with lower socio-
economic status, but there is no evidence that comorbidities make a new diagnosis less likely. 
On the contrary, a higher number of comorbid conditions in older people may be associated 
with higher quality of care 
27
. We found different patterns in different conditions, which fits 
with other research showing that wealth acts differently in different conditions, and for 
example, has no association with referral for post-menopausal bleeding 
28
. Major national 
policy interventions such as the Quality and Outcomes Framework payment for performance 
scheme in primary care 
29
 have been associated with improved healthcare for included 
conditions such as angina and diabetes, more than for excluded conditions such osteoarthritis 
and poor vision 
30-32
. 
 
The serial cross-sectional analysis of 4 waves of ELSA included all eligible participants in 
each wave in order to maximise the sample size. This approach meant that some participants 
with a diagnosed condition would no longer have had symptoms or raised biomarkers, if they 
were being successfully treated. Examples would be diabetic participants whose blood sugar 
levels were being successfully controlled by treatment, and participants with successfully 
treated depression. We therefore checked our main results with the secondary (longitudinal) 
analysis, which assessed subsequent diagnosis in those had met the criteria for ‘illness 
burden’, and subsequent treatment in those with a medical diagnosis, but the number of 
participants who could be followed through the waves in this way was too small to allow 
meaningful conclusions to be drawn from the results. 
 
Our results fit with previous findings that a greater proportion of people in deprived groups 
had Rose angina, but there was no difference in the proportions receiving a general 
practitioner diagnosis of coronary heart disease 
14
. Care-seeking behaviour and patient 
preferences may differ with wealth. Given the same information, patients may want fewer 
medical interventions than their doctors recommend 
33;34
, and pessimism about availability of 
treatment may make older people reluctant to seek help 
35
. Older people may view living with 
symptoms (such as pain, or emotional problems) as a normal part of ageing 
36
. The response 
of the primary care physician may also vary with the wealth of the patient. For example, the 
physician might be more likely to consider symptoms of breathlessness as a medical problem 
requiring a diagnosis, whereas aches and pains, poor vision, and low mood might be 
considered part of the tapestry of life, or the natural ageing process. Comorbidity is more 
common in deprived populations, and may make diagnosis of all conditions harder for 
doctors within the constraints of a short consultation 
37
. 
 
At a system level, the results may be partially explained by wealthier people living in areas 
where there are more healthcare resources. Wennberg introduced the concept of ‘supply-
sensitive care’ to describe how the quantity of healthcare resources allocated to a particular 
population was a major determinant of the frequency of use of health services by that 
population, and gives an example in which ‘a doubling of the supply of internists or 
cardiologists results in roughly a halving of the interval between repeat visits’ 
38;39
. Where 
healthcare resources are relatively plentiful, patients with chronic diseases will consult more, 
use more diagnostic tests, and be referred to hospital more. Further research could helpfully 
investigate whether those missing out on diagnosis are not accessing health services, or are 
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seeing a doctor but not being diagnosed. The participants were selected to be nationally 
representative of the population of England, and so the findings are likely to be generalisable 
to England, but not to countries with different healthcare systems.  If validated, our findings 
that inequalities in receipt of diagnoses are potential barriers to equitable healthcare for five 
common long-term conditions, suggest that future policy interventions to reduce socio-
economic inequalities in healthcare should consider improving access to diagnosis as well as 
treatment.  
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Supplemental file 1 
 
Supplemental Table 1. Odds ratios for meeting the ‘illness burden’ criteria for angina, 
cataract, depression, diabetes and osteoarthritis, medical diagnosis for those estimated to have 
a condition, and treatment for those with a diagnosis, comparing the least wealthy with the 
most wealthy: binomial regression 
  Adjusted odds ratios* (95% CI)  
Condition Illness burden  
 
(Wave 3) 
Medical 
diagnosis 
(Wave 4) 
Treatment  
 
(Wave 5) 
N in treatment† 
Angina 8.7 (5.5, 13.8) 1.4 (0.5, 4.0) 1.6 (0.3, 9.0) 11 
Cataract 8.2 (5.1, 13.1) 1.0 (0.3, 3.1) 2.2 (1.2, 3.8) 83 
Osteoarthritis 12.7 (9.1, 17.8) 0.7 (0.3, 1.6) 0.7 (0.3, 1.6) 30 
     
 Illness burden  
 
(Wave 2) 
Medical 
diagnosis 
(Wave 3) 
Treatment  
 
(Wave 4) 
N in treatment† 
Depression 5.1 (4.3, 6.2) 0.4 (0.1, 1.4) 17.3 (0.5, 604) 12 
Diabetes 4.4 (2.5, 8.0) 0.1 (0.0, 3.6) 0.5 (0.2, 1.1) 99 
     
*adjusted for age group and sex 
†followed through the waves 
Waves used in analysis were the most recent with available data 
Odds ratios where the 95% confidence intervals do not include 1 (before rounding to one 
decimal place) are shown in bold 
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STROBE 2007 (v4) Statement—Checklist of items that should be included in reports of cross-sectional studies 
 
Section/Topic Item 
# 
Recommendation Reported on page # 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1&2 
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 2 
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 4 
Objectives 3 State specific objectives, including any prespecified hypotheses 4 
Methods  
Study design 4 Present key elements of study design early in the paper 4-6 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data 
collection 
4-5 
Participants 
 
6 
 
(a) Give the eligibility criteria, and the sources and methods of selection of participants 4-6 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
5 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe 
comparability of assessment methods if there is more than one group 
5 
Bias 9 Describe any efforts to address potential sources of bias 6 
Study size 10 Explain how the study size was arrived at 6 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and 
why 
6 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 6 
 
 
 
 
(b) Describe any methods used to examine subgroups and interactions 6 
(c) Explain how missing data were addressed 6 
(d) If applicable, describe analytical methods taking account of sampling strategy 6 
(e) Describe any sensitivity analyses 6 
Results    
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Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, 
confirmed eligible, included in the study, completing follow-up, and analysed 
6-8 
  (b) Give reasons for non-participation at each stage 6-8 
  (c) Consider use of a flow diagram  
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential 
confounders 
7 
  (b) Indicate number of participants with missing data for each variable of interest  
Outcome data 15* Report numbers of outcome events or summary measures 8 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for and why they were included 
7-9 
  (b) Report category boundaries when continuous variables were categorized 7 
  (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period  
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 7 
Discussion    
Key results 18 Summarise key results with reference to study objectives 10 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
10-11 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
11 
Generalisability 21 Discuss the generalisability (external validity) of the study results 11-12 
Other information    
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on 
which the present article is based 
12 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE 
checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org. 
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